Lawsuit On Sale Of Investigational Drugs Divides Oncology Community
Executive Summary
Allowing patients to buy investigational drugs would undermine FDA's clinical trial system, medical groups contend in a pair of amicus briefs seeking to reverse an appeals court ruling
You may also be interested in...
FDA Can Expand Access To Experimental Drugs, Without Compromising Trials
FDA would be able to maintain the integrity of rigorous clinical trials and permit increased access to experimental drugs through the use of better science, according to former FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb
FDA Can Expand Access To Experimental Drugs, Without Compromising Trials
FDA would be able to maintain the integrity of rigorous clinical trials and permit increased access to experimental drugs through the use of better science, according to former FDA Deputy Commissioner for Medical & Scientific Affairs Scott Gottlieb
FDA Expanded Access Proposals Too Narrow For Patient Advocates
The Abigail Alliance's response to an FDA proposal on expanded access to investigational drugs suggests the patient advocacy group will continue to pursue legal action against the agency